Anti-PD-L1/B7-H1 Antibody (29E.2A3)
Anti-PD-L1/B7-H1 Antibody (29E.2A3) is a kind of mouse IgG2b κ chimeric antibody inhibitor, targeting to human PD-L1/B7-H1. Anti-PD-L1/B7-H1 Antibody (29E.2A3) can block the binding of PD-1 to PD-L1. Anti-PD-L1/B7-H1 Antibody (29E.2A3) can be used for the research of infection, such as hepatitis C virus (HCV) [1][2].
Product Specifications
CAS Number
9007-83-4
UNSPSC
12352203
Hazard Statement
H302, H315, H319, H335
Target
PD-1/PD-L1
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/anti-pd-l1-b7-h1-antibody-29e-2a3.html
Purity
99
Smiles
[Anti-PD-L1/B7-H1Antibody(29E.2A3)]
Molecular Weight
(150 kDa)
Precautions
H302, H315, H319, H335
References & Citations
[1]Broos K, et al. Single Domain Antibody-Mediated Blockade of Programmed Death-Ligand 1 on Dendritic Cells Enhances CD8 T-cell Activation and Cytokine Production. Vaccines (Basel) . 2019 Aug 7;7 (3) :85.|[2]Nakamoto N, et al. Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade. PLoS Pathog. 2009 Feb;5 (2) :e1000313.
Shipping Conditions
Blue Ice
Storage Conditions
Store at 4°C for 2 years, do not freeze
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC470181-500 1x 500 µL
CD59 (heavy chain of Protectin) (BRA-10G), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470669-500 1x 500 µL
P27 / KIP1 (SX53G8), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040525-100 1x 100 µL
CD63 (MX-49.129.5), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC401274-500 1x 500 µL
Cytokeratin 10 (Suprabasal Epithelial Marker) (AE20), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470159-100 1x 100 µL
Mucin 1 / EMA / Episialin / CD227 (GP1.4), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details